Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers

Dena Davidson, Chandan Saha, Stephanie Scifres, Joanne Daggy, Sean O'Connor, Christopher Selzer

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The present study examined the utility of daily naltrexone for decreasing alcohol drinking in hazardous drinkers. Forty-one participants participated in a 10-week trial and received 30 min of brief counseling on the first and second week of treatment, as well as a daily dose of 50 mg of naltrexone throughout the trial. Overall, naltrexone-treated participants did not show the same degree of improvement on drinking outcomes as placebo-treated participants. The placebo group drank fewer drinks per drinking day and achieved more abstinence days than the naltrexone group. Craving was also lower for the placebo group. The groups were not balanced on gender or family history of alcoholism and this may explain the lack of effect of naltrexone on the drinking outcomes.

Original languageEnglish
Pages (from-to)1253-1258
Number of pages6
JournalAddictive Behaviors
Volume29
Issue number6
DOIs
StatePublished - Aug 2004

Fingerprint

Naltrexone
Drinking
Counseling
Placebos
Alcohol Drinking
Alcoholism
Alcohols

Keywords

  • Hazardous drinkers
  • Heavy drinking
  • Naltrexone

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers. / Davidson, Dena; Saha, Chandan; Scifres, Stephanie; Daggy, Joanne; O'Connor, Sean; Selzer, Christopher.

In: Addictive Behaviors, Vol. 29, No. 6, 08.2004, p. 1253-1258.

Research output: Contribution to journalArticle

Davidson, Dena ; Saha, Chandan ; Scifres, Stephanie ; Daggy, Joanne ; O'Connor, Sean ; Selzer, Christopher. / Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers. In: Addictive Behaviors. 2004 ; Vol. 29, No. 6. pp. 1253-1258.
@article{f1a7fbf5cf66433eb4b4baf236b3b0ae,
title = "Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers",
abstract = "The present study examined the utility of daily naltrexone for decreasing alcohol drinking in hazardous drinkers. Forty-one participants participated in a 10-week trial and received 30 min of brief counseling on the first and second week of treatment, as well as a daily dose of 50 mg of naltrexone throughout the trial. Overall, naltrexone-treated participants did not show the same degree of improvement on drinking outcomes as placebo-treated participants. The placebo group drank fewer drinks per drinking day and achieved more abstinence days than the naltrexone group. Craving was also lower for the placebo group. The groups were not balanced on gender or family history of alcoholism and this may explain the lack of effect of naltrexone on the drinking outcomes.",
keywords = "Hazardous drinkers, Heavy drinking, Naltrexone",
author = "Dena Davidson and Chandan Saha and Stephanie Scifres and Joanne Daggy and Sean O'Connor and Christopher Selzer",
year = "2004",
month = "8",
doi = "10.1016/j.addbeh.2004.03.027",
language = "English",
volume = "29",
pages = "1253--1258",
journal = "Addictive Behaviors",
issn = "0306-4603",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers

AU - Davidson, Dena

AU - Saha, Chandan

AU - Scifres, Stephanie

AU - Daggy, Joanne

AU - O'Connor, Sean

AU - Selzer, Christopher

PY - 2004/8

Y1 - 2004/8

N2 - The present study examined the utility of daily naltrexone for decreasing alcohol drinking in hazardous drinkers. Forty-one participants participated in a 10-week trial and received 30 min of brief counseling on the first and second week of treatment, as well as a daily dose of 50 mg of naltrexone throughout the trial. Overall, naltrexone-treated participants did not show the same degree of improvement on drinking outcomes as placebo-treated participants. The placebo group drank fewer drinks per drinking day and achieved more abstinence days than the naltrexone group. Craving was also lower for the placebo group. The groups were not balanced on gender or family history of alcoholism and this may explain the lack of effect of naltrexone on the drinking outcomes.

AB - The present study examined the utility of daily naltrexone for decreasing alcohol drinking in hazardous drinkers. Forty-one participants participated in a 10-week trial and received 30 min of brief counseling on the first and second week of treatment, as well as a daily dose of 50 mg of naltrexone throughout the trial. Overall, naltrexone-treated participants did not show the same degree of improvement on drinking outcomes as placebo-treated participants. The placebo group drank fewer drinks per drinking day and achieved more abstinence days than the naltrexone group. Craving was also lower for the placebo group. The groups were not balanced on gender or family history of alcoholism and this may explain the lack of effect of naltrexone on the drinking outcomes.

KW - Hazardous drinkers

KW - Heavy drinking

KW - Naltrexone

UR - http://www.scopus.com/inward/record.url?scp=3242714311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242714311&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2004.03.027

DO - 10.1016/j.addbeh.2004.03.027

M3 - Article

C2 - 15236831

AN - SCOPUS:3242714311

VL - 29

SP - 1253

EP - 1258

JO - Addictive Behaviors

JF - Addictive Behaviors

SN - 0306-4603

IS - 6

ER -